Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Annals of Nuclear Medicine|November 10, 2019
Quantitative bone scan imaging using BSI and BUV: an approach to evaluate ARONJ earlyYayoi Yamamoto, Sachiyo Mitsunaga, Ayumi Horikawa, et al.Brain, Behavior, & Immunity - Health|February 3, 2026
Quinolinic acid as trigger/biomarker of dysosmia/dysgeusia in patients with acute coronavirus disease 2019: A retrospective case-control studyJun Tsukiji, Shiro Koizume, Tomoko Takahashi, et al.Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|July 6, 2012
Cervicofacial subcutaneous and mediastinal emphysema caused by air cooling spray of dental laserSachiyo Mitsunaga, Toshinori Iwai, Noriaki Aoki, et al.Head and Neck Pathology|April 5, 2017
Predictive Significance of Tumor Depth and Budding for Late Lymph Node Metastases in Patients with Clinical N0 Early Oral Tongue CarcinomaYukiko Hori, Akira Kubota, Tomoyuki Yokose, et al.Journal of Radiation Research|February 22, 2021
A cost-minimization analysis of measures against metallic dental restorations for head and neck radiotherapyKouji Katsura, Yoshihiko Soga, Sadatomo Zenda, et al.BMC Cancer|January 8, 2021
Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BCKatsuhiko Nakatsukasa, Naoki Niikura, Kosuke Kashiwabara, et al.Annals of Translational Medicine|May 14, 2021
Oral care and oral assessment guide in breast cancer patients receiving everolimus and exemestane: subanalysis of a randomized controlled trial (Oral Care-BC)Masahiro Umeda, Yoshihide Ota, Kosuke Kashiwabara, et al.The Oncologist|February 12, 2020
Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor-Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care-BC): A Randomized Controlled Phase III TrialNaoki Niikura, Katsuhiko Nakatukasa, Takeshi Amemiya, et al.Pageof 1